Clinical Trials Directory

Trials / Terminated

TerminatedNCT01170468

Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals

Does Vitamin D Reduce Risk of Developing Type II DM in Prediabetics? A Double Blind Randomized Controlled Trial

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
25 (actual)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Both vitamin D deficiency and type II DM/prediabetes are highly prevalent. Vitamin D status has been negatively associated with the presence of type II DM and glycemic control. A cause-effect relationship between vitamin D deficiency and the development of type II DM has not been established. The investigators plan to conduct a 2 year, double blind, randomized, placebo controlled trial on the effect of vitamin D3 supplement on the incidence of type II DM in high risk individuals.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3Vitamin D3 5000 IU orally, daily for 2 years
DRUGPlaceboPlacebo orally, daily for 2 years

Timeline

Start date
2011-12-01
Primary completion
2014-01-15
Completion
2014-01-15
First posted
2010-07-27
Last updated
2018-03-07

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT01170468. Inclusion in this directory is not an endorsement.